Your browser doesn't support javascript.
loading
Rituximab therapy for refractory autoimmune bullous diseases: A multicenter, open-label, single-arm, phase 1/2 study on 10 Japanese patients.
Kurihara, Yuichi; Yamagami, Jun; Funakoshi, Takeru; Ishii, Maki; Miyamoto, Julia; Fujio, Yumi; Kakuta, Risa; Tanikawa, Akiko; Aoyama, Yumi; Iwatsuki, Keiji; Ishii, Norito; Hashimoto, Takashi; Nishie, Wataru; Shimizu, Hiroshi; Kouyama, Keisuke; Amagai, Masayuki.
Afiliación
  • Kurihara Y; Department of Dermatology, Keio University School of Medicine, Tokyo, Japan.
  • Yamagami J; Department of Dermatology, Keio University School of Medicine, Tokyo, Japan.
  • Funakoshi T; Department of Dermatology, Keio University School of Medicine, Tokyo, Japan.
  • Ishii M; Department of Dermatology, Keio University School of Medicine, Tokyo, Japan.
  • Miyamoto J; Department of Dermatology, Keio University School of Medicine, Tokyo, Japan.
  • Fujio Y; Department of Dermatology, Keio University School of Medicine, Tokyo, Japan.
  • Kakuta R; Department of Dermatology, Keio University School of Medicine, Tokyo, Japan.
  • Tanikawa A; Department of Dermatology, Keio University School of Medicine, Tokyo, Japan.
  • Aoyama Y; Department of Dermatology, Okayama University School of Medicine, Okayama, Japan.
  • Iwatsuki K; Department of dermatology, Kawasaki Medical School, Kurashiki, Japan.
  • Ishii N; Department of Dermatology, Okayama University School of Medicine, Okayama, Japan.
  • Hashimoto T; Department of Dermatology, Kurume University School of Medicine, Kurume, Japan.
  • Nishie W; Department of Dermatology, Kurume University School of Medicine, Kurume, Japan.
  • Shimizu H; Department of Dermatology, Hokkaido University School of Medicine, Sapporo, Japan.
  • Kouyama K; Department of Dermatology, Hokkaido University School of Medicine, Sapporo, Japan.
  • Amagai M; Clinical and Translational Research Center, Keio University Hospital and Keio University School of Medicine, Tokyo, Japan.
J Dermatol ; 46(2): 124-130, 2019 Feb.
Article en En | MEDLINE | ID: mdl-30585649
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Enfermedades Cutáneas Vesiculoampollosas / Rituximab / Factores Inmunológicos Tipo de estudio: Clinical_trials / Observational_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged País/Región como asunto: Asia Idioma: En Revista: J Dermatol Año: 2019 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Enfermedades Cutáneas Vesiculoampollosas / Rituximab / Factores Inmunológicos Tipo de estudio: Clinical_trials / Observational_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged País/Región como asunto: Asia Idioma: En Revista: J Dermatol Año: 2019 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Reino Unido